🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bsn Capital Partners - Q1 2026 13F Filings

BS

Bsn Capital Partners LTD

CIK: 0001911876
Address: United Kingdom London First Floor 18-19 Pall Mall
$2.12 B
Portfolio Value
24
Assets Held
Reporting Period: Q1 2026
Filing Status:
Active
Last Updated: 06/30/2026

Portfolio Summary (Q1 2026)

View Full Portfolio Analysis

Top Buys

Q1 2026

Top Sells

Q1 2026

Asset Allocation

Stocks/ETFs
+66.64%
$2.12 B 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Bsn Capital Partners Q1 2026 Filing Summary

Bsn Capital Partners LTD originally filed its 13F report for Q1 2026 on April 27, 2026. The filing was subsequently amended, with the latest update submitted on June 30, 2026. The portfolio totaled 2.12 B reflecting a +66.64% change from the prior quarter, spanning 24 assets. The top 10 holdings comprised 83.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 17 new positions and 9 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Bsn Capital Partners’s Q1 2026 Filing

Yes. Bsn Capital Partners originally filed on 04/27/2026 and subsequently submitted 1 amendment(s). The latest filing (13F-HR/A) was submitted on 06/30/2026.

In the Q1 2026 filing, Bsn Capital Partners reported a managed portfolio value of 0, consisting of 1 individual positions.

Multiple filings indicate that Bsn Capital Partners updated their Q1 2026 report. The initial filing was submitted on 04/27/2026, followed by amendments to correct data or disclose previously confidential holdings.

This page displays the raw filing documents. To see which stocks Bsn Capital Partners bought or sold during Q1 2026, please visit Bsn Capital Partners's Portfolio Analysis page.